Natl Dense Breast Disclosure Law (9/10/2024) Video Part 1
HealthTech Reporter* is the tech review e-magazine of the Integrative Pain Healers Alliance produced to showcase the performance or intended benefits of health and medical devices based on direct test drives/demos or actual user reporting and interviews.
Tuesday, October 1, 2024
Wednesday, September 25, 2024
Thursday, August 22, 2024
SPINAL ALIGNMENT INNOVATION REVEALS NEW BENEFITS
SONIK Treatment Solution for Post-Neurosurgery Imbalance
By: Russ Allen, correspondent for HealthTech Reporter
Around the end of 2019, my wife, Kaye was diagnosed with a non-cancerous tumor of the brain, the size of a golf ball. It was determined that surgery was needed. The tumor was sitting right on top of her Pineal gland and resulted in a number of different symptoms. A neurovascular surgeon from New York (Dr. Ng Lin) conducted an MRI guided surgery and was able to successfully excise the tumor without any apparent damage to the brain.
After that, she had a number of issues with balance and her gait, suspected to be a rare, poorly understood disorder called MAL DE DEBARQUEMENT (MDD) – an issue in the vestibular system that results in a phantom perception of self- motion typically described as rocking, bobbing or swaying. The symptoms tend to be exacerbated when a patient is not moving, for example, when sleeping or standing still- appearing like motion sickness. (1)The inventor of the MRI, Dr. Robert Damadian conducted a post-surgery Fonar MRI while she was sitting up (upper left image) and was able to monitor the brain. He detected a certain amount of seepage of cerebral fluid into the lower left posterior portion of the brain, which he surmised caused Kaye’s MDD symptoms.
Kaye and I sought a non-surgical solution to this disorder. We identified the work of Dr. Aslam Khan, the inventor of the SONIK treatment solution as our best option. In discussions with Dr Khan, we learned of the benefits of Dr. Khan’s medical solutions technology utilizing the SONIK medical device which uses sound waves to mitigate the many issues from spine injuries. A precursor to the SONIK device has been in the clinical market for over 20 years and continues to support the orthopedic community with compelling results(3). It targets the core issues of spinal-related conditions that often lead to painful structural, muscular, and neurological challenges.
In Kaye’s case, she was treated with the device (emitting the pulsed impulses through the device stylus) which is a scientifically validated, non-invasive treatment methodology(2).
We were hoping for an improvement in her gait and balance, which was achieved. An additional unexpected benefit also emerged. The condition observed from the pre-treatment FONAR MRI by Dr Damadian, which displayed the seepage of cerebral fluid did not appear in the MRI scan by Dr Lin that was done post SONIK treatment.
Through to date, my wife feels great. Her imbalance symptoms have been resolved. She functions normally; she hikes, she rides bikes daily and goes up and down stairs regularly. She remains careful with stairs.
Our experience and assessment of the SONIK treatment and Dr. Khan’s concepts of SONIK medicine remains a remarkable find. Our confidence in Dr. Khan also continues to grow as clinics are expanding throughout the globe- from Canada, the US, Saudi Arabia, Germany, Taiwan, Qatar and more. As a supporter of breakthrough alternative and functional innovations, this technology continues to inspire exploration. Having the privilege of experiencing this innovation, my wife and I both fully embrace and endorse the expanded research on the use of this impressive science which Dr. Khan’s clinical leadership had pioneered.
Dr Damadian Pretreatment MRI Scan
Dr Lin Post MRI Scan
EPILOGUE
8/13/2024- Dr. Aslam Khan and Dr. Robert Bard meet for the first time in person to explore collaborative partnerships in support of breakthrough therapeutic technologies. Dr. Bard, the founder and patriarch of clinical imaging validation through advanced (quantitative) 3D Ultrasound imaging and key principal researcher for IHRC (Integrative Health Research Center, NYC) has expressed major interest in supporting the expansion of Dr. Khan’s Sonik solution and the vast potential applications of the SONIK technology. Dr. Bard helped pioneer the use of ultrasound technology in the paradigm of image guided therapies for cancer care and tumor management. His commitment to advance the expansion of point-of-care ultrasound globally and his support of the non-invasive (non-surgical) movement in medicine aligns with Dr. Khan’s philosophies for treatment and pain care. “To explore where science and medicine has yet to boldly go where no one has gone before- like the TRICORDER, (a Star Trek Reference) its where we need to be. Cutting into the body would someday be a thing of the past… and the impact of energy medicine like this is truly the future that we are finally driving right now”, says Dr. Bard.
References:
1) National Organization for Rare Disorders [Mal de Debarquement]: https://rarediseases.org/rare-diseases/mal-de-debarquement/
2) KKT is a neurospinal innovation/ https://sonik.health/sonik-treatment.php
3) Innovation factory: https://innovationfactory.ca/clients/neuro-spinal-innovation/
Monday, August 12, 2024
TechReview: Exploring the DermaSensor™
Until recently, the approach of identifying skin cancers was commonly a visual self-exam or a clinical exam conducted by a health care provider and/or a dermatologist. A skin biopsy is the only way to definitively diagnose skin cancer- where a small sample of the suspicious skin is removed and sent to a lab for examination (under a microscope) in search of cancer cells.HEALTHTECH REPORTER is proud to introduce another non-invasive advancement in skin cancer diagnostics. DermaSensor™ is an AI powered, FDA-cleared innovation designed to help physicians detect skin cancer at the point of care. According to a recent DEMO DAY @ Bard Diagnostics in NYC, clinical educators provided a comprehensive tour of what appears to be a ground-breaking innovation for primary care physicians "offering actionable results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically".
DermaSensor™ was designed as a portable and fast-access noninvasive point-of-care assessment tool for primary care physicians to offer additional information about a lesion to aid in their consideration of a referral decision. (DermaSensor™ does not definitively determine whether or not cancer is present, specify what type of cancer may be present, or make any decision for the user.)
By examining the difference in light scattering, DermaSensor™ determines if the skin lesion suggests to “Investigate Further” or “Monitor” - as an immediate output. Elastic Scattering Spectroscopy (ESS) has been validated in 30+ publications on clinical studies. Many studies have shown ESS to provide information that is comparable to histopathologic assessment in the analysis of cellular microscopic structure.*
 (Image 1-Right) The solid red line is malignant melanocytic lesions. The solid blue line is benign melanocytic lesions and the dotted lines are for malignant non-melanocytic and benign non-melanocytic lesions. And the separation here is the varying spectral signatures for these different categories, and it uses dozens of these wavelengths to discern malignant from benign tissue. for example, it does not use ~600 microns in the center where the lines overlap. That's the reflectance of hemoglobin. |
According to Dr. Kiran Chatha (medical science liaison), DermaSensor™ uses the science of Elastic Scattering Spectroscopy layered with a machine learning algorithm. ESS shines visual light from approximately 350 to 850 nanometers of light onto a given lesion. Based on the reflectance of the intensity of the photons of light, it's able to create a chart which is then compared to spectral signatures which are validated for different tissue types. DermaSensor’s™ tip reflects and records pulses of light off the lesion’s cellular and sub-cellular content. The built-in computer analyzes the light to provide information to help physicians assess skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) to aid in a referral decision.
DEMO DAY:
DERMASENSOR PERFORMANCE TEST By Dr. Robert L. Bard
When our scheduler locked down an official device demo of the DermaSensor™, my skin imaging team and I were excited to explore the future of skin cancer detection and how AI truly plays a role in intelligent scanning. This is the first that we have experienced that inspired the level of confidence to provide immediate objective cancer risk information to PCPs. We originally learned about this technology from Dr. Alina Bridges, Dermatopathologist @ Northwell Health and research collaborator for the DermaSensor™ team. She presented her involvement in an upcoming (FDNY) firefighter skin cancer screening promoted by the American Academy of Dermatology. She also mentioned the technology was being considered for the program. Though the AAD did not learn of this technology in time to evaluate it for this program, she piqued our interest in this device and the science of Elastic Scattering Spectroscopy (EES) as one that may raise the bar for skin cancer detection. We stacked the day with patients with chronic skin disorders from basal cell carcinoma, squamous cell carcinoma, and melanoma. We also brought in patients who recently underwent mohs surgeries to remove malignant lesions. One by one, the device was surprisingly 'spot on' with its challenge to determine the skin pathologies of each volunteer. We found this performance test to fully quantify each lesion.
My research group conducted their own homework on the technology and found their R&D efforts to rank highly in accuracy and efficacy. With their reported sensitivity rating of 96% and a negative predictive value of 97%, the science of a non-invasive, portable, AI-powered data scanning aligns with our entire med-tech movement trends.
As a skin cancer radiologist, I have always been passionate about validating pathologies based on a comparative (side by side) view from above the skin and underneath. I relied on the latest quantitative imaging solutions (3D Doppler Ultrasound, Reflectance Confocal Microscopy etc). This DermaSensor™ satisfies both the current status of the malignancy, but its database guides the physician as far as what the malignancy could mean and recommends next steps.
Beneath this simple-looking device holds a vast amount of data to identify a skin anomaly and its malignancy. I'm told that it is a common question to ask whether this competes with dermatologists, but I immediately see how this actually elevates the reliance between the PCP and the skin specialist. My colleagues in the dermatology society would certainly welcome the benefits that it provides in 1) resulting in more skin cancers detected and referred from primary care, and 2) the objective risk output helps PCPs prioritize referral of high-risk lesions with a PPV of 40% for 8-10 scores (i.e. a NNR of 2.5).
Overall, we found the technology to be quite intelligent and expect the patient care market to embrace this device. It is priced well and is backed by a significant amount of proven research. Their team of dermatology and primary care medical advisors and research collaborators are certainly well recognized in the industry, winning significant votes of confidence within the medical community.
DERMASENSOR MAKES MEDICAL NEWS
In January 2024, DermaSensor™ received official FDA clearance of its First-In-Class Device and is shaping the future of its market by winning deserved recognition and innovation awards for its continued advancement in cancer diagnostics. An article in Nature agrees, as it describes the FDA’s authorization of this device as “a pivotal moment in digital health innovation” and “establishes a new regulatory precedent for FDA authorization of medical devices incorporating AI and ML technologies within dermatology.”
SPECIAL THANKS: We wish to express our deep appreciation for the generosity of Mr. Cody Simmons (CEO), Dr. Kiran Chatha, Ms. Ruth Stachura and Dr. Alina Bridges- with whose kind efforts this report could not have been made possible. Healthtech Reporter and Dr. Bard are in no way compensated nor otherwise conflicted with DermaSensor, Inc.
 THE CRITICAL ROLE OF DIAGNOSTICS IN HEALTH AND WELLNESS By: Dr. Jess Sabrowsky DNP, RN, FNP-BC  We need to use technology, diagnostics, and assessment techniques to gather real data. Data that can guide each patient on their unique health journey. Diagnostics help us understand the true state of a person’s health, even when they may not feel “sick.” This is where the rubber meets the road: when you find a PCP who truly understands the importance of these tools and works with you to achieve your wellness goals and who also has skills beyond the transitional medical model to help you live your best life. Having difficult conversations is uncomfortable, but it is necessary for growth. If you want a healthcare provider who will partner with you—someone who creates a safe space, builds trust, and encourages honest dialogue to support long-term growth—then you must also be willing to put in the effort. Finding a provider who matches your commitment to your health, and one who uses diagnostics to empower you, is key to achieving your goals.  In short, diagnostics are essential because they offer concrete, actionable insights into your health that go beyond surface-level symptoms. They help uncover hidden health risks and enable early intervention, which can be the difference between preventing a chronic condition or managing it effectively. Diagnostics allow for personalized care tailoring interventions to meet the specific needs of the individual based on real, measurable data. I also would add that as a provider I prefer to reference functional lab ranges when reviewing results as I find that I can make small preventative recommendations and also challenge individuals and providers to think outside the box when looking to help resolve health conditions, like in the case of my daughter who otherwise would still be suffering. Let’s aim to stop the suffering and optimize wellness for all who seek it. |
Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (HealthTechReporter.com, Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.
Friday, July 26, 2024
KHAN
this device kind of falls between, um, so from a realignment perspective, you know, we, we do what we do, uh, and very, very, very, you know, very objectively, and it's also, uh, very visually appealing. Um, and it re it removes the need for, you know, cracking and pulling people's back and, and snapping them and giving them TIAs. Um, so, so that's one side of it, uh, does it consistently without any, you know, with, without any deliberation whatsoever. Um, and as precisely as it's humanly possible. So that's one side of it. On the other side, from a regenerative standpoint, it almost, you know, people who would normally be using PRP and, and, and trying to, you know, uh, experiment with stem cells and all of that, this kind of knocks it out out of the park. So we get tremendous immediate outcomes where there is to the knee, to the shoulder, to soft tissue, and, and most importantly, to cartilage and ligaments. Where that, where that sort of Absolutely.
So, so where we are with the technology is that, is that currently, I mean, our, our most, the most important thing right now is to be able to put this hand, the technology to the hands of, of clinicians, you know, across the country. That's got to happen. I mean, we just cannot delay anymore. It's, it's, uh, you know, it's, it's, it's, it's, it's so delayed in for, you know, in getting to, into the hands of the clinicians to begin with that I feel guilty about it every single day. And, um, and I think, you know, the, the needless pain and suffering of patients is, is what kind of drives me crazy. You know, every time I think about all the people who are, you know, suffering where this technology in a matter of minutes can change their life, um, you know, and they don't have access to it. And now we've got an FDA clearance, we have the whole, everything is wide open for us. And, uh, now it's just a matter of really placing into the hands of, of, well-meaning people.
I can take all the credit for it, but, you know, somewhere, somehow things came and happened and I walked into it and, uh, and I think it was, it was truly a game changer for us to be able to use sound in, in treatment, uh, starting many years ago. And, um, and I think what you'll, what you'll find is that, um, in the years to come, this is going to be the cornerstone of how we apply medicine. There is no question. If there's one thing I can leave behind in this conversation, it's that watch out because there is laser use and there's, you know, there's many other uses as well, uh, chemical use of drugs and surgery and, and, uh, and when it comes to the non-invasive sites, some of the injections and everything, and now they've, they've done their part.
But when it comes to sound, the, the, the, the implication, the opportunity of being able to tailor it to each person's individual, you know, their own profile, their own individual profile, we just don't have anything that even comes close to that with any other technology. And, you know, and so, um, you know, I think it was, I was very fortunate I walked into it by mistake. And, um, and, you know, I, I opened the curtain and I said, what the hell is this? And, and before I knew it, I had engineers, scientists, researchers working on it, and they spent 10 years of, you know, I spent 10 years of my life just going through the, you know, the grind. And, um, and, but at every corner, the beauty was that at every corner, whenever I would, you know, I would make the next, you know, I would open up the next chapter, I would see something amazing that was even bigger than I imagined.
I think, I think the beauty is that today, um, the technology has arrived, you know, and, um, and, and, and now in terms of the clinicians, I mean, you know, the joy is that, you know, the more brilliant a clinician and the more thoughtful a clinician is, the more they'll enjoy it and the more they'll discover things that nobody else has discovered and it's at their fingertips, they can apply it. And as long as they're able to capture before and after, they'll know what needs to be done.
this is gonna be the future of medicine in a big way. It's not gonna be exclusively to this obviously, like everything else, but it's gonna be, it's gonna take on a huge part of our life. If you remember how our man on Star Trek would hold up this, this device and, you know, every time Bones would see somebody with, with an injury, he'd put it up against him. And well, you know, everything else came true in, of Star Trek, whether it was a cell phone or whatever else there was out there in those days. Um, I'm talking about, I'm going back to the original Star Trek, by the way. Unfortunately, I'm dating myself.
Tuesday, July 16, 2024
THERMOGRAM - a Tech Review by Dr. Leslie Valle-Montoya
Disclaimer: This is an independent user review by the speaker(s) presenting in this feature. The producers of HealthTech Reporter do not guarantee outcomes of any product nor commercially endorse technologies nor the users who report of them.
WORK IN PROGRESS- DO NOT DISTRIBUTE (INTERNAL USE ONLY)
 |
| Click to enlarge |
First, what is Regulation Thermometry?
Regulation Thermometry uses mathematics and infrared
sensors which are calibrated for the human body and involves analyzing changes
in skin temperatures before and after exposure to a cool air stimulus. The
connections between the skin and the channels with internal organs, this method
allows for the indirect assessment of organ and tissue systems. It is
achieved by utilizing the spinal reflex arc and the expression of the
Autonomic Nervous System where peripheral nerves connect with organ and tissue
signals. The test takes 20 minutes and results are immediate for assessment by
the physician.
A traditional thermography scan looks at thermal images caused by vascular components and heat patterns and/or anomalies. And the scan is done once without the component of stressing the system. Regulation thermography measures the physiological changes from stress to the whole body to analyze signatures patterns of regulation and dysregulation.
Side Note: The biggest feature I see with Regulation thermography is the ability to have a panoramic dental evaluation of all 32 teeth. Embryological development of our teeth correlates to an organ and related system of our whole body. In my training of Biological Medicine, I was guided to analyze dental health first before bypassing the mouth and looking at family history and labs. The mouth is part of our terrain and it needs to be incorporated into our medical wellbeing. Biological dentist are impressed when their patients come with a copy of their thermography report alarming where there could be a potential infection in the making.
Applications in Preventive Health: Thermography has a wide range of preventative applications. It is particularly effective in monitoring breast health, where early detection of anomalies can significantly improve treatment outcomes. By using thermography, healthcare providers can track changes over time and identify issues before they develop into more serious conditions. And changes can be measured frequently non-invasively and radiation-free. This makes it a safe option for regular monitoring, without the risks associated with repeated exposure to radiation.
ANECDOTAL COMPARISONS WITH OTHER DIAGNOSTIC OPTIONS:
Preventative measures: An imbalance and dysfunction can lead to disease. We want to pick up dysfunction at an early stage and do true preventative medicine to change the dysfunction. This technology plays a crucial role in preventative health care. It is not necessary to wait until a certain age to use diagnostics tools to look for abnormalities. By detecting heat patterns and anomalies in the body, it provides valuable insights that can help in early diagnosis and monitoring of various health conditions.
Conclusion: Recently an article by Journal Cell Metabolism collected over 2,800 facial thermal imaging analysis to reveal the hallmarks of aging and metabolic diseases (Yu et al., July 2, 2024). Alfa thermography offers a valuable tool using a whole body temperature sensor with infrared coupling- measuring the small temperature changes on the skin. Its non-invasive nature and ability to detect early signs of abnormalities make it an excellent option for regular health check-ups and preventative medicine. We need to see that the points measured in the body can regulate themselves. Which translates as tissues able to heal themselves. By incorporating thermography into your health regimen, you can take proactive steps towards maintaining your well-being and catching potential issues early.
Tuesday, May 28, 2024
DR. GIOVANNA FERRAIOLI: DIAGNOSTIC LIVER RESEARCH ON THE INTERNATIONAL FRONT LINES
I am a hepatologist working at The University of Padua, in Northern Italy (near Milan). I'm conducting the research on liver elastography- assessing diffuse liver disease using elastography for almost 20 years.
We started first with the FibroScan®- a dedicated device that assesses the stiffness of the liver while using an ultrasound equipment were available. I started doing research in this case; we use the limb biopsy as the reference standard to assess the accuracy of the method. We found that elastography was a very accurate method for detecting and staging liver fibrosis. Currently elastography is used as a reliable substitute for liver biopsy in several clinicals, scenarios and guidelines.
The World Federation (Forza Medicine and Biology) of Societies for ultrasound medicine and Biology have given all the information we needed about how to perform elastography, and how it can be used not only for staging liver fibrosis, but also for evaluating the outcome of patients affected with diffuse liver disease. Just a few months ago, we completed the guidelines and updated to the guidelines for assessing the liver fibrosis with Shearwave elastography with the guidelines of the World Federation of for ultrasound in medicine and biology. Several studies have been published on hundred of studies using Shearwave for diffuse liver disease.
Cytosis is assessed with another method that is not elastography. There are other algorithms, however, patients with cytosis are the majority of patients with diffuse liver disease. We want to assess both the stiffness that is directly related to liver fibrosis and quantifying the amount of fat in the liver.
There are specific algorithms for the quantification of liver fat content, and the majority are based on calculating the attenuation coefficient of the ultrasound beam as it traverses the liver tissue. Stiffness is a different property of the liver tissue. Stiffness assess biomechanical properties of a tissue that is unrelated to the acoustic properties of a tissue.
So the art ultrasound, we may find B mode image that is pretty good, but, uh, the liver may be stiffer than normal, and this is due mostly to liver fibrosis. Even though there are, uh, confounding factors, we are assessing stiffness, stiffness may increase not only for liver fibrosis, but also for the inflammation, for infiltrative disease, for, uh, congestive art disease, and, uh, for, uh, cancer, for, uh, focal liver lesions. Elastography, uh, doesn't have a, um, uh, principle role, uh, mostly used for diffuse liver disease for focal level lesions.
Speaker 1 (05:03):
And to, um, characterize them, uh, we use the contrast, the contrast ultrasound that is, uh, completely different. Uh, at the beginning there were, uh, some studies performed assessing the stiffness of a focal lesions, uh, however they say large overlap between, uh, bine and, and malignant liver lesion. And for that reason, elastography has not a, a, a key role in, uh, assessing, uh, focal lesions. Instead for, uh, diffuse liver disease, uh, elastography is a substitute of biopsy, absolutely, yes. But it's already, uh, used for breast. And in, uh, 2015, the world of federation for, uh, art, ultrasound, medicine, and biology. I mean, 10 years ago, uh, issued guidelines for the use of elastography in, uh, breast disease for, uh, assessing, uh, the lesion, uh, in the breast. And now, um, I believe that this year, uh, the update to the guidelines for the breast graphy will be available.
Speaker 1 (06:27):
So, uh, besides, um, the liver, the breast is the organ that is most studied with using elastography. It's used, it's not as easy to perform as we do for, uh, the liver because, uh, it needs, uh, expertise. And again, if you want more detailed information, uh, there, say a, a worldwide expert in, uh, breast elastography living in the states and working in the states in Ohio. That is, uh, Dr. Richard Barr. And you may, uh, reach him if you want to have more details on the use of breast tractography. Uh, we have an, uh, ultrasound school in, uh, <inaudible> that is, uh, endorsed by the Italian Society for Art, ultrasound Medicine in biology. And, uh, we have a colleagues that, uh, attend the school, uh, for practice. And, uh, uh, they are medical doctors in Italy. We do not have, uh, sonographers as in other countries in, uh, Europe.
Speaker 1 (07:44):
So they attend the school to learn now to perform elastography. And generally we have, uh, between 30 and 50, uh, colleagues, uh, each year. They, uh, follow the activity of the ultrasound, uh, uh, unit for, uh, several months. And they get a diploma, uh, by the, uh, endorse by the, uh, Italian society, uh, for razza in medicine and biology. Then we also, uh, have an <inaudible> school. Theum is the European Federation for Razza in Medicine and Biology, and this is a more advanced school for, uh, leader <inaudible>. And to learn how to, uh, perform and to practice in the, our, uh, department and for photo quantification. And we accept, uh, colleagues from, uh, all over the world. We are the colleagues from, uh, Brazil, Argentina, and, uh, other countries in, uh, Europe. They, uh, attend, um, short course, um, generally three days course to learn how to perform as ultrasound, uh, in ay.
Subscribe to:
Posts (Atom)
-
IPHA NEWS and HEALTH TECH REPORTER covers DEMO DAY at the Bard Diagnostic Imaging Center in NYC @ March 7, 2023. National clinical trainer ... -
In our continued search for the next voice in support of Integrative and Functional wellness, our editors opted to follow the trail of innov... -
Until recently, the approach of identifying skin cancers was commonly a visual self-exam or a clinical exam conducted by a health care provi...